SCHEMBL9896255

SCHEMBL9896255

COc1ccc(-c2ncnc3c(C(=O)N[C@H]4CC[C@@H](NC(C)=O)CC4)c(C)[nH]c23)c(OCC2CC2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.39
CYP4A11 Q02928 1/20 0.39
GRIN1 Q05586 1/20 0.37
GRIN2B Q13224 1/20 0.37
RIPK2 O43353 2/20 0.36
CDK9 P50750 2/20 0.36
CASP3 P42574 1/20 0.36
CASP7 P55210 1/20 0.36
CRHR1 P34998 2/20 0.35
CRHR2 Q13324 2/20 0.35
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
RAB9A P51151 1/20 0.34
CDK1 P06493 1/20 0.34
CDK2 P24941 1/20 0.34
KDM4E B2RXH2 1/20 0.34
HPGDS O60760 2/20 0.34
PAK1 Q13153 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9896257 1.00 CYP4F2 (0.39) CYP4F2CYP4A11GRIN1GRIN2BRIPK2
SCHEMBL9898024 1.00 CYP4F2 (0.39) CYP4F2CYP4A11GRIN1GRIN2BRIPK2
SCHEMBL9897220 0.94 GRIN1 (0.38) GRIN1GRIN2BRIPK2CRHR1CRHR2
SCHEMBL9896147 0.94 GRIN1 (0.38) GRIN1GRIN2BRIPK2CRHR1CRHR2
SCHEMBL9896151 0.94 GRIN1 (0.38) GRIN1GRIN2BRIPK2CRHR1CRHR2
SCHEMBL9895179 0.94 CYP4F2 (0.39) CYP4F2CYP4A11GRIN1GRIN2BRIPK2
SCHEMBL9897562 0.94 CYP4F2 (0.39) CYP4F2CYP4A11GRIN1GRIN2BRIPK2
SCHEMBL9895181 0.94 CYP4F2 (0.39) CYP4F2CYP4A11GRIN1GRIN2BRIPK2
Hydrochloric Acid SCHEMBL9897483 0.92 BTK (0.37) GRIN1GRIN2BRIPK2CRHR1CRHR2
Hydrochloric Acid SCHEMBL9897043 0.92 BTK (0.37) GRIN1GRIN2BRIPK2CRHR1CRHR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9376442-B2 Methylpyrrolopyrimidinecarboxamides TAKEDA GMBH (DE) 2016-06-28 US claimed
US-20150073001-A1 METHYLPYRROLOPYRIMIDINECARBOXAMIDES ASTRAZENECA AB (SE) 2015-03-12 US claimed
US-8927557-B2 Methylpyrrolopyrimidinecarboxamides TAKEDA GMBH (DE) 2015-01-06 US claimed
EP-2470536-B1 Methylpyrrolopyrimidinecarboxamides TAKEDA GMBH (DE) 2014-11-12 EP claimed
US-20120149721-A1 METHYLPYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2012-06-14 US claimed
US-9376442-B2 Methylpyrrolopyrimidinecarboxamides TAKEDA GMBH (DE) 2016-06-28 US disclosed
US-20150073001-A1 METHYLPYRROLOPYRIMIDINECARBOXAMIDES ASTRAZENECA AB (SE) 2015-03-12 US disclosed
US-8927557-B2 Methylpyrrolopyrimidinecarboxamides TAKEDA GMBH (DE) 2015-01-06 US disclosed
EP-2470536-B1 Methylpyrrolopyrimidinecarboxamides TAKEDA GMBH (DE) 2014-11-12 EP disclosed
US-20120149721-A1 METHYLPYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149721-A1 METHYLPYRROLOPYRIMIDINECARBOXAMIDES PDE5A, PDE12, PDE4A CYP4F2 349/4885CYP4A11 584/4885GRIN1 2957/4885
US-20150073001-A1 METHYLPYRROLOPYRIMIDINECARBOXAMIDES PDE12, PDE5A, PDE4A CYP4F2 395/4885CYP4A11 643/4885GRIN1 4046/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.